NASDAQ : AUTL

Autolus Therapeutics plc — Financial statements

Healthcare · Biotechnology · United Kingdom

Last price 1.45 USD (Nov 2, 2026, 11:48 AM EST) · Market cap 385.94M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Autolus Therapeutics plc (AUTL) reported revenue of 117.39M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue117.39M75.39M10.12M1.70M6.36M2.33M
Cost of Revenue204.97M207.38M141.02M122.31M117.35M110.84M
Gross Profit-87.58M-132.00M-130.90M-120.62M-110.99M-108.51M
Selling, General & Admin159.51M138.20M110.11M54.91M31.90M31.86M
Operating Expenses159.51M138.20M110.11M54.91M31.90M31.86M
Operating Income-247.09M-270.19M-241.01M-175.53M-142.89M-140.37M
Interest Expense-45.15M-42.37M-39.94M-45.07M-8.90M-1.10M
Interest & Investment Income11.96M18.98M32.35M13.51M1.71M262.00K
Currency Exchange Gain (Loss)-2.72M2.16M-989.00K2.64M1.80M-2.30M
Other Non Operating Income (Expenses)3.88M6.21M30.86M222.00K338.00K155.00K
EBT Excluding Unusual Items-279.13M-285.21M-218.72M-204.23M-147.95M-143.36M
Gain (Loss) on Sale of Assets-3.79M-515.00K-676.00K
Asset Writedown-349.00K-349.00K-414.00K-382.00K
Other Unusual Items-100.00K2.00M
Pretax Income-279.48M-285.56M-219.13M-208.40M-148.57M-142.04M
Income Tax Expense677.00K1.97M1.53M-19.00K272.00K58.00K
Net Income-280.16M-287.53M-220.66M-208.38M-148.84M-142.10M
Net Income to Common-280.16M-287.53M-220.66M-208.38M-148.84M-142.10M
Shares Outstanding (Basic)266.15M266.14M255.16M173.94M94.99M72.08M
Shares Outstanding (Diluted)266.15M266.14M255.16M173.94M94.99M72.08M
EPS (Basic)-1.05-1.08-0.86-1.20-1.57-1.97
EPS (Diluted)-1.05-1.08-0.86-1.20-1.57-1.97
Free Cash Flow-232.73M-302.61M-228.35M-156.57M-123.15M-126.72M
Free Cash Flow Per Share-0.87-1.14-0.90-0.90-1.30-1.76
Gross Margin-74.60%-175.09%
Operating Margin-210.49%-358.41%-2,381.54%-10,337.34%-2,246.74%-6,024.64%
Profit Margin-238.65%-381.40%-2,180.45%-12,272.26%-2,340.24%-6,098.54%
Free Cash Flow Margin-198.25%-401.41%-2,256.38%-9,221.02%-1,936.31%-5,438.54%
EBITDA-236.57M-260.38M-233.30M-168.96M-135.54M-132.01M
D&A For EBITDA10.52M9.81M7.72M6.57M7.36M8.37M
EBIT-247.09M-270.19M-241.01M-175.53M-142.89M-140.37M
Revenue as Reported117.39M75.39M10.12M1.70M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents171.41M104.13M227.38M239.57M382.44M310.34M
Short-Term Investments30.22M196.58M360.64M
Cash & Short-Term Investments201.63M300.71M588.02M239.57M382.44M310.34M
Accounts Receivable44.91M24.55M945.00K1.05M153.00K68.00K
Other Receivables32.65M51.24M47.30M23.50M28.82M26.18M
Receivables77.56M75.79M48.24M24.54M28.98M26.25M
Inventory33.43M33.21M4.14M
Prepaid Expenses19.34M21.27M15.21M8.64M12.34M8.71M
Restricted Cash1.50M1.50M1.43M769.00K325.00K338.00K
Other Current Assets2.64M3.43M3.89M1.79M1.70M1.31M
Total Current Assets336.09M435.92M660.93M275.30M425.77M346.95M
Property, Plant & Equipment134.63M128.50M105.05M95.65M58.42M52.32M
Other Intangible Assets18.53M19.81M12.37M65.00K
Long-Term Deferred Tax Assets2.79M3.56M3.24M3.06M2.08M1.83M
Other Long-Term Assets1.18M1.28M1.13M1.36M4.01M4.40M
Total Assets493.23M589.07M782.73M375.38M490.27M405.56M
Accounts Payable1.37M3.08M1.97M103.00K531.00K431.00K
Accrued Expenses46.27M53.76M51.80M39.05M40.40M23.51M
Current Portion of Leases5.79M4.57M3.00M5.05M5.04M4.45M
Other Current Liabilities2.46M12.03M3.98M533.00K393.00K160.00K
Total Current Liabilities68.79M73.44M60.74M44.74M46.37M28.55M
Long-Term Debt271.40M270.20M244.60M170.90M125.90M47.02M
Long-Term Leases77.72M66.82M49.63M47.91M19.22M16.55M
Other Long-Term Liabilities474.00K477.00K426.00K357.00K116.00K128.00K
Total Liabilities418.39M410.94M355.40M263.91M191.60M92.24M
Common Stock12.00K12.00K12.00K8.00K8.00K4.00K
Additional Paid-In Capital1.58B1.57B1.56B1.02B1.01B843.11M
Retained Earnings-1.50B-1.39B-1.10B-878.56M-670.18M-521.34M
Comprehensive Income & Other-5.98M-5.24M-29.06M-28.87M-38.78M-8.45M
Shareholders' Equity74.84M178.13M427.32M111.47M298.67M313.32M
Total Liabilities & Equity493.23M589.07M782.73M375.38M490.27M405.56M
Total Debt367.81M341.59M297.23M223.87M150.16M68.01M
Net Cash (Debt)-166.18M-40.88M290.79M15.70M232.28M242.32M
Net Cash Per Share-0.62-0.151.140.092.453.36
Filing Date Shares Outstanding266.16M266.14M266.13M265.93M173.07M90.91M
Total Common Shares Outstanding266.15M266.14M266.12M174.10M173.07M90.91M
Working Capital267.30M362.48M600.19M230.56M379.40M318.40M
Book Value Per Share0.280.671.610.641.733.45
Tangible Book Value56.31M158.32M414.95M111.47M298.67M313.25M
Tangible Book Value Per Share0.210.591.560.641.733.45
Machinery64.08M65.12M50.42M38.37M35.98M38.92M
Construction In Progress12.06M27.07M19.64M12.54M13.19M2.44M
Leasehold Improvements32.20M15.76M14.12M12.73M11.69M14.90M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-280.16M-287.53M-220.66M-208.38M-148.84M-142.10M
Depreciation & Amortization10.52M9.81M7.72M6.57M7.36M8.37M
Other Amortization65.00K90.00K
Loss (Gain) From Sale of Assets13.00K14.00K223.00K3.79M515.00K672.00K
Asset Writedown & Restructuring Costs642.00K349.00K414.00K382.00K
Loss (Gain) From Sale of Investments-4.32M-8.19M-1.25M
Stock-Based Compensation15.44M14.44M15.47M11.20M12.01M9.94M
Other Operating Activities53.22M39.52M15.47M40.56M16.04M4.76M
Change in Accounts Receivable-17.81M-24.16M
Change in Inventory-22.45M-40.25M-4.23M
Change in Accounts Payable-3.94M1.30M1.59M-509.00K22.00K-1.82M
Change in Other Net Operating Assets25.32M11.12M-21.02M801.00K514.00K2.23M
Operating Cash Flow-225.61M-283.57M-206.27M-145.59M-112.31M-117.86M
Capital Expenditures-7.12M-19.04M-22.07M-10.99M-10.84M-8.86M
Sale (Purchase) of Intangibles-8.09M-8.09M-12.74M
Investment in Securities301.35M185.59M-359.73M
Investing Cash Flow286.14M158.46M-394.55M-10.99M-10.84M-8.86M
Issuance of Common Stock3.00K550.58M27.00K163.97M246.03M
Other Financing Activities-7.78M-4.34M38.98M-910.00K59.64M38.04M
Financing Cash Flow-7.77M-4.34M589.55M-883.00K223.61M284.06M
Foreign Exchange Rate Adjustments-5.18M6.28M-261.00K15.03M-28.38M-754.00K
Net Cash Flow47.58M-123.17M-11.53M-142.43M72.08M156.59M
Free Cash Flow-232.73M-302.61M-228.35M-156.57M-123.15M-126.72M
Free Cash Flow Margin-198.25%-401.41%-2,256.38%-9,221.02%-1,936.31%-5,438.54%
Free Cash Flow Per Share-0.87-1.14-0.90-0.90-1.30-1.76
Levered Free Cash Flow-201.19M-249.40M-206.33M-125.13M-75.76M-77.76M
Unlevered Free Cash Flow-172.97M-222.92M-181.37M-96.97M-70.20M-77.07M
Cash Income Tax Paid2.24M1.97M2.39M551.00K471.00K364.00K
Change in Working Capital-20.97M-51.99M-23.66M292.00K536.00K410.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization385.94M529.63M625.39M1.12B328.81M378.45M
Enterprise Value552.12M487.39M269.49M1.06B233.33M227.20M
Last Close Price1.521.992.356.441.905.19
PS Ratio3.457.0361.80659.6951.70162.43
PB Ratio5.412.971.4610.051.101.21
P/TBV Ratio7.193.351.5110.051.101.21
EV/Sales Ratio4.866.4626.63622.4836.6997.51
Debt / Equity Ratio4.921.920.702.010.500.22
Net Debt / Equity Ratio2.220.23-0.68-0.14-0.78-0.77
Net Debt / EBITDA Ratio-0.70-0.161.250.091.711.84
Net Debt / FCF Ratio-0.71-0.141.270.101.891.91
Asset Turnover0.190.110.020.000.010.01
Inventory Turnover7.1411.11
Quick Ratio4.065.1310.475.908.8711.79
Current Ratio4.895.9410.886.159.1812.15
Return on Equity (ROE)-133.00%-94.98%-81.91%-101.61%-48.64%-54.30%
Return on Assets (ROA)-25.44%-24.62%-26.01%-25.35%-19.94%-25.07%
Return on Capital Employed (ROCE)-58.20%-52.40%-33.40%-53.10%-32.20%-37.20%
Earnings Yield-72.60%-54.29%-35.28%-18.60%-45.27%-37.55%
FCF Yield-57.53%-57.14%-36.51%-13.98%-37.45%-33.48%
Buyback Yield / Dilution-2.10%-4.30%-46.69%-83.11%-31.78%-39.81%